Today's Trend
Bath & Body Works, Inc. (NYSE: BBWI) shares are higher following a strong Q1 update that topped expectations and reignited investor optimism around the company’s turnaround strategy. The stock’s move appears to be driven primarily by better-than-expected earnings and sales, plus commentary that the “Consumer First Formula” is gaining traction and could support stronger results in 2026 and 2027.
- Bath & Body Works beat Q1 estimates, with sales and earnings coming in ahead of Wall Street expectations; investors are also encouraged by management’s upbeat outlook for growth momentum over the next two years. Reuters: Bath & Body Works beats quarterly estimates on strong demand for 'affordable luxury'
- TD Cowen raised its price target on BBWI to $25 and reiterated a buy rating, signaling confidence in further upside from current levels. Tickerreport.com: Bath & Body Works price target raised by TD Cowen
- Recent coverage highlights that investors are focusing on valuation, dividend appeal, and potential Amazon-related growth opportunities, which may be helping support the rally. MarketBeat: Bath & Body Works Stock Surged Despite Falling Sales—Here’s Why
- Wells Fargo, Telsey Advisory Group, and Goldman Sachs all trimmed their price targets, but maintained ratings that range from overweight to neutral, suggesting analysts still see value even as they moderate expectations. The Fly: analyst target changes
- Brokerage consensus remains at “Hold,” indicating the market is still waiting for proof that the earnings beat can translate into sustained growth. American Banking News: Bath & Body Works receives consensus recommendation of Hold
Overall, BBWI looks to be rising because investors are prioritizing the earnings beat and improved growth narrative over ongoing sales softness, while analyst commentary has mostly reinforced the view that the stock still has room to run.